Zentalis Pharmaceuticals Inc.
ZNTL | NASDAQ
$3.08
+$0.05 (+1.65%)
Sep 22, 2026, 12:20 PM ET · Market open
TTM Period Ending | Q2 2026 Jun 29, 2026 | Q1 2026 Mar 30, 2026 | Q4 2025 Dec 30, 2025 | Q3 2025 Sep 29, 2025 | Q2 2025 Jun 29, 2025 | Q1 2025 Mar 30, 2025 | Q4 2024 Dec 30, 2024 | Q3 2024 Sep 29, 2024 | Q2 2024 Jun 29, 2024 | Q1 2024 Mar 30, 2024 | Q4 2023 Dec 30, 2023 | Q3 2023 Sep 29, 2023 | Q2 2023 Jun 29, 2023 | Q1 2023 Mar 30, 2023 | Q4 2022 Dec 30, 2022 | Q3 2022 Sep 29, 2022 | Q2 2022 Jun 29, 2022 | Q1 2022 Mar 30, 2022 | Q4 2021 Dec 30, 2021 | Q3 2021 Sep 29, 2021 | Q2 2021 Jun 29, 2021 | Q1 2021 Mar 30, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Income | -174.9M | -124.13M | -137.06M | -149.32M | -162.78M | -224.19M | -165.84M | -179.28M | -194.67M | -218.95M | -292.28M | -286.35M | -285.31M | -241.14M | -237.11M | -232.19M | -188.18M | -174.85M | -165.51M | -155.81M | -179.98M | -151.78M |
Depreciation & Amortization | 772K | 628K | 739K | 899K | 1.06M | 1.23M | 1.29M | 1.31M | 1.34M | 1.35M | 1.39M | 1.41M | 1.44M | 1.44M | 1.43M | 1.28M | 1.04M | 809K | 544K | 368K | 282K | 201K |
Stock-Based Compensation | 14.36M | 14.24M | 20.72M | 48.96M | 54.5M | 60.92M | 67.27M | 35.91M | 39.41M | 40.04M | 40.94M | 50.55M | 47M | 50.43M | 46.84M | 37.23M | 34.57M | 27.72M | 17.58M | 25.46M | 25.06M | 15.14M |
Other Working Capital | -89K | 1.16M | 1.22M | 2.35M | 8.27M | 8.32M | 6.48M | 5.87M | -431K | -3.5M | -6.47M | -18.45M | -13.73M | -14.57M | -13.25M | -481K | 1.59M | 104K | 2.23M | 1.07M | -5.31M | -5.97M |
Other Non-Cash Items | 985K | -4.69M | -526K | -22.3M | -25.52M | 6.43M | -59.6M | -30.49M | -25.3M | -25.78M | 37.12M | 31.88M | 35.1M | 14.77M | 12.66M | 18.67M | -25.84M | -30.8M | -23.26M | -33.4M | 10.16M | 17.24M |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -756K | -853K | -1.62M | -1.75M | -917K | -894K | -140K | -15K | -89K | n/a | 32K | 32K | 32K |
Change in Working Capital | -2.27M | -11.6M | -9.12M | -12.26M | -18.35M | 4.08M | -13.98M | 804K | 12.84M | -6.42M | 5.86M | -421K | 4.43M | 12.58M | 13.33M | 11.71M | 14.69M | 10.38M | 16.56M | 18.92M | 12.95M | 11.75M |
Operating Cash Flow | -161.05M | -125.57M | -125.25M | -134.01M | -151.09M | -151.52M | -170.86M | -171.76M | -166.38M | -210.51M | -207.82M | -204.55M | -199.09M | -162.84M | -163.75M | -163.44M | -163.73M | -166.82M | -154.09M | -144.43M | -131.5M | -107.42M |
Capital Expenditures | -68K | -34K | n/a | n/a | n/a | -181K | -221K | -394K | -485K | -623K | -583K | -570K | -2.14M | -2.1M | -2.55M | -4.58M | -5.58M | -6.12M | -6.11M | -4.58M | -1.96M | -1.16M |
Cash Acquisitions | 569K | 1.13M | 1.14M | 569K | 569K | 70K | 65K | 65K | 182.36K | 44.11K | 44.11K | 55.84K | -83.2K | 131.88K | 131.88K | 120.14K | 141.82K | n/a | n/a | -108.24M | -108.24M | -89.81M |
Purchase of Investments | -169.65M | -149.91M | -139.49M | -148.47M | -158.17M | -137.38M | -127.96M | -184.73M | -389.61M | -495.42M | -549.18M | -579.18M | -444.67M | -517.79M | -533.16M | -490.4M | -563.27M | -388.33M | -363.51M | -377.18M | -341.56M | -455.42M |
Sales Maturities Of Investments | 320.41M | 270.41M | 270.41M | 279.36M | 308.98M | 292.98M | 304.68M | 287.28M | 326.55M | 471.01M | 505.31M | 565.46M | 569.99M | 428.03M | 421.53M | 435.96M | 362.69M | 396.99M | 365.82M | 325.05M | 276.04M | 185.24M |
Other Investing Acitivies | -440K | -440K | -440K | n/a | n/a | n/a | n/a | n/a | -117.36K | -44.11K | -44.11K | -55.84K | 83.2K | -131.88K | -131.88K | -120.14K | -14.46M | -14.32M | -14.32M | 93.92M | 108.24M | 108.24M |
Investing Cash Flow | 150.82M | 121.16M | 131.62M | 131.46M | 151.38M | 155.49M | 176.56M | 102.22M | -63.48M | -25.03M | -44.46M | -14.29M | 123.18M | -91.86M | -114.18M | -59.02M | -220.48M | -11.78M | -18.12M | -71.03M | -67.48M | -252.92M |
Debt Repayment | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | -2.91M | -1.45M | n/a | n/a | n/a | n/a | -241K | -241K | -241K | -241K | n/a | n/a | n/a | n/a | n/a | -1.15M | -760K | -1.15M | -1.15M | n/a | -386K | n/a |
Financial Cash Flow | -6.65M | -5.59M | -4.28M | 304K | 281K | 290K | 108K | 108K | 325K | 236.94M | 237.3M | 287.04M | 287.32M | 260.16M | 261.04M | 223.57M | 389.55M | 179.78M | 178.52M | 165.66M | 154.99M | 328.54M |
Net Cash Flow | -16.88M | -10M | 2.09M | -2.25M | 623K | 4.31M | 5.86M | -69.43M | -229.58M | 1.34M | -15.03M | 68.2M | 211.42M | 5.47M | -16.89M | 1.5M | 5.73M | 1.58M | 4.76M | -51.75M | -45.94M | -33.75M |
Free Cash Flow | -161.12M | -125.6M | -125.25M | -134.01M | -151.09M | -151.7M | -171.08M | -172.15M | -166.86M | -211.14M | -208.41M | -205.12M | -201.23M | -164.94M | -166.3M | -168.02M | -169.31M | -172.94M | -160.2M | -149.01M | -133.46M | -108.59M |
Adj. Free Cash Flow | -175.48M | -139.84M | -145.97M | -182.97M | -205.59M | -212.63M | -238.35M | -208.06M | -206.27M | -251.18M | -249.35M | -255.68M | -248.23M | -215.36M | -213.14M | -205.25M | -203.88M | -200.66M | -177.78M | -174.47M | -158.52M | -123.72M |
Maintenance CapEx | -68K | -34K | n/a | n/a | n/a | -181K | -181K | -354K | -445K | -583K | -583K | -570K | -2.14M | -2.1M | -2.55M | -4.58M | -5.58M | -6.12M | -6.11M | -4.58M | -1.96M | -1.16M |
Growth CapEx | n/a | n/a | n/a | n/a | n/a | n/a | -40K | -40K | -40K | -40K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Owner Earnings | -161.12M | -125.6M | -125.25M | -134.01M | -151.09M | -151.7M | -171.04M | -172.11M | -166.82M | -211.1M | -208.41M | -205.12M | -201.23M | -164.94M | -166.3M | -168.02M | -169.31M | -172.94M | -160.2M | -149.01M | -133.46M | -108.59M |
Add to Watchlist
Select watchlists to add or remove ZNTL